HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22.

Abstract
Familial lipodystrophy is a genetically heterogeneous set of disorders characterized by a total or partial absence of subcutaneous fat, diabetes mellitus or impaired glucose tolerance, hyperlipidemia, and hypermetabolism [Senior and Gellis, 1964]. One subtype, familial partial lipodystrophy Dunnigan (FPLD), is a rare autosomal dominant trait that results in an gradual loss of subcutaneous fat in the lower trunk and limbs, Type V hyperlipoproteinemia, hypertriglyceridemia, and insulin-resistant diabetes. Previous reports of this condition have been limited to case reports or very small families. Recently, Peters et al. reported on linkage of five families of Western European descent to a 5.3 cM region on chromosome 1q21-22 between the flanking markers D1S305 and D1S1600 [Peters et al., 1998: Nat Genet 18:292-295]. We performed linkage and haplotype analysis using highly polymorphic, microsatellite markers on a large, multigeneration Caucasian kindred of German ancestry. The maximum two-point lod score achieved was 4.96 at theta(max) = 0 for marker D1S2721. Multipoint analysis gave an overall maximum lod score of 6.27 near marker D1S2721. The results of the haplotype analysis support the minimal candidate region as reported by Peters et al.
AuthorsJ L Anderson, M Khan, W S David, Z Mahdavi, F Q Nuttall, E Krech, S G West, J M Vance, M A Pericak-Vance, M A Nance
JournalAmerican journal of medical genetics (Am J Med Genet) Vol. 82 Issue 2 Pg. 161-5 (Jan 15 1999) ISSN: 0148-7299 [Print] United States
PMID9934982 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Adult
  • Chromosome Mapping
  • Chromosomes, Human, Pair 1
  • Female
  • Genetic Linkage
  • Haplotypes
  • Humans
  • Lipodystrophy (genetics)
  • Male
  • Pedigree

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: